000 | 01696 a2200505 4500 | ||
---|---|---|---|
005 | 20250512145625.0 | ||
264 | 0 | _c19720309 | |
008 | 197203s 0 0 eng d | ||
022 | _a0041-008X | ||
024 | 7 |
_a10.1016/0041-008x(71)90275-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCapel-Edwards, K | |
245 | 0 | 0 |
_aHematological changes observed in female beagle given ethynylestradiol. _h[electronic resource] |
260 |
_bToxicology and applied pharmacology _cNov 1971 |
||
300 |
_a319-26 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Cells _xdrug effects |
650 | 0 | 4 | _aBlood Coagulation Tests |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 | _aBlood Sedimentation |
650 | 0 | 4 |
_aBone Marrow _xdrug effects |
650 | 0 | 4 | _aBone Marrow Cells |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aErythrocyte Count |
650 | 0 | 4 |
_aErythrocytes _xdrug effects |
650 | 0 | 4 |
_aEstrus _xdrug effects |
650 | 0 | 4 |
_aEthinyl Estradiol _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHematocrit |
650 | 0 | 4 |
_aHemorrhagic Disorders _xchemically induced |
650 | 0 | 4 |
_aHyperplasia _xchemically induced |
650 | 0 | 4 | _aLeukocyte Count |
650 | 0 | 4 |
_aLeukocytes _xdrug effects |
650 | 0 | 4 |
_aLeukocytosis _xchemically induced |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aProthrombin Time |
650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aHall, D E | |
700 | 1 | _aSansom, A G | |
773 | 0 |
_tToxicology and applied pharmacology _gvol. 20 _gno. 3 _gp. 319-26 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0041-008x(71)90275-4 _zAvailable from publisher's website |
999 |
_c5169327 _d5169327 |